Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
M. Arora, C. Cutler, M. Jagasia, et al.. (2016). Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Cited 147 times. https://doi.org/10.1016/j.bbmt.2015.10.018
Biomarker Panel for Chronic Graft-Versus-Host Disease.
Jeffrey S. Yu, B. Storer, K. Kushekhar, et al.. (2016). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 126 times. https://doi.org/10.1200/JCO.2015.65.9615
Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.
Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD.
Stephanie J. Lee. (2011). Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Cited 43 times. https://doi.org/10.1016/j.bbmt.2011.05.007
Proteomic Characterization Reveals That MMP‐3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation
Xiaowen Liu, Zongliang Yue, Jeffrey S. Yu, et al.. (2016). American Journal of Transplantation. Cited 33 times. https://doi.org/10.1111/ajt.13750
Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.
